Doximity, Inc. $DOCS Stock: VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stake

VIRGINIA RETIREMENT SYSTEMS ET Al decreased its position in shares of Doximity, Inc. (NYSE:DOCS) by 36.9% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,095 shares of the company’s stock after selling 26,938 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Doximity were worth $1,306,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Carmignac Gestion increased its stake in Doximity by 127.8% in the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after buying an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Doximity by 24.7% in the second quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after acquiring an additional 621,464 shares in the last quarter. Quantinno Capital Management LP lifted its position in shares of Doximity by 420.5% in the first quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock valued at $3,270,000 after acquiring an additional 113,380 shares in the last quarter. Royal Bank of Canada lifted its position in shares of Doximity by 28.4% in the first quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock valued at $4,806,000 after acquiring an additional 45,618 shares in the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in shares of Doximity in the third quarter worth about $28,858,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Up 6.3%

Shares of DOCS stock opened at $34.64 on Thursday. The stock has a market cap of $6.17 billion, a P/E ratio of 35.82, a PEG ratio of 25.50 and a beta of 1.29. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $66.11. The company’s fifty day simple moving average is $28.78 and its two-hundred day simple moving average is $25.59.

Doximity (NYSE:DOCS) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.16 by $0.13. The business had revenue of $156.62 million during the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period last year, the company earned $0.36 EPS. On average, analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Insider Transactions at Doximity

In other news, Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $32.89, for a total value of $65,780.00. Following the sale, the director directly owned 27,923 shares of the company’s stock, valued at approximately $918,387.47. The trade was a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,613 shares of the business’s stock in a transaction dated Wednesday, October 14th. The stock was sold at an average price of $30.68, for a total value of $80,166.84. Following the completion of the sale, the chief accounting officer owned 101,432 shares in the company, valued at $3,111,933.76. This represents a 2.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 21,250 shares of company stock valued at $679,635. 31.80% of the stock is owned by company insiders.

More Doximity News

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Valuation commentary points to potential upside: one article says a model sees about 53% upside, and another describes Doximity as roughly 3% undervalued following its DoseCheck and UpToDate rollout. These are model-based assessments, not guarantees or new company guidance. Earnings To Watch: Doximity Inc (DOCS) Q2 2027 — GF Value Sees 53% Upside Doximity Could Be 3% Undervalued Following DoseCheck And UpToDate Rollout
• Neutral Sentiment: Investors are looking ahead to Doximity’s fiscal Q2 2027 results for the quarter ended September 2026. The articles preview Wall Street estimates and key metrics but do not report results, so they provide no confirmed earnings surprise. Q2 Performance and Wall Street Estimates
• Negative Sentiment: Several law firms are publicizing a pending securities class action and a November 16, 2026 lead-plaintiff deadline. The complaint alleges Doximity overstated the Newsfeed product’s contribution to revenue growth and its competitive position; these are allegations, not established findings. Litigation can add uncertainty and reputational risk. DOCS Securities Class Action Deadline Alert

Analyst Ratings Changes

Several research firms recently issued reports on DOCS. Evercore set a $35.00 target price on Doximity in a research report on Tuesday, September 29th. Stifel Nicolaus set a $27.00 target price on Doximity in a research note on Tuesday, September 8th. Truist Financial boosted their price target on Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Thursday, August 13th. BMO Capital Markets restated a “market perform” rating and issued a $30.00 price target on shares of Doximity in a research note on Friday, August 7th. Finally, Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and set a $18.00 price objective for the company. in a report on Monday, August 10th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $30.73.

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.